tiprankstipranks
Trending News
More News >
Procter & Gamble (PG)
NYSE:PG
US Market
Advertisement

Procter & Gamble (PG) Drug Pipeline

Compare
15,633 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice, Electric Toothbrush, Cetylpyridinium Chloride (Cpc), Manual Toothbrush
Gingivitis
Phase IV
Completed
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
Sep 29, 2025
Sodium Monofluorophosphate Dentifrice, Stannous Fluoride Dentifrice, Test Stannous Fluoride Dentifrice
Gingivitis
Phase IV
Active Not Recruiting
Assessing Gingivitis and Plaque From a Marketed Toothpaste
Aug 28, 2025
0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice
Gingivitis
Phase I
Active Not Recruiting
Evaluating Gingivitis and Systemic Biomarkers
Apr 30, 2025
Sodium Monofluorophosphate Dentifrice, Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice
Gingivitis
Phase II
Completed
Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.
Mar 19, 2025
0 Ppm F, 250 Ppm F As Mfp, 1100 Ppm As Mfp, 2800 Ppm F As Mfp
Caries
Phase I
Completed
Salivary Fluoride Clearance
Dec 11, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Procter & Gamble (PG) have in its pipeline
      PG is currently developing the following drugs: Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice, Electric Toothbrush, Cetylpyridinium Chloride (Cpc), Manual Toothbrush, Sodium Monofluorophosphate Dentifrice, Stannous Fluoride Dentifrice, Test Stannous Fluoride Dentifrice, 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis